Viatris Wins Landmark First US Interchangeability Designation For Semglee

Allows Pharmacy Substitution For Insulin Glargine Biosimilar Rival To Lantus

Interchangeable Swap Icon
Viatris’ Semglee will now be able to be substituted for Lantus • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products